Colinz Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 17.15 million compared to INR 16.8 million a year ago. Revenue was INR 17.62 million compared to INR 17.23 million a year ago. Net income was INR 1.06 million compared to INR 1.03 million a year ago. Basic earnings per share from continuing operations was INR 0.42 compared to INR 0.41 a year ago. Diluted earnings per share from continuing operations was INR 0.42 compared to INR 0.41 a year ago.
For the nine months, sales was INR 54 million compared to INR 54.34 million a year ago. Revenue was INR 55.68 million compared to INR 55.64 million a year ago. Net income was INR 3.51 million compared to INR 3.3 million a year ago. Basic earnings per share from continuing operations was INR 1.39 compared to INR 1.31 a year ago. Diluted earnings per share from continuing operations was INR 1.39 compared to INR 1.31 a year ago.